Andrea Gombos - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

2020 The Lancet 1658 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi , William Jacot , Toshinari Yamashita +35 more

In this trial involving patients with HER2-low metastatic breast cancer, trastuzumab deruxtecan resulted in significantly longer progression-free and overall survival than the p...

2022 New England Journal of Medicine 2161 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,819
Institution: Institut Jules Bordet

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1664-2369

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.